Plunkett Research Online: Myrexis, Inc.

MYREXIS, INC. (MYRX:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Myrexis Inc is engaged in evaluating strategic alternatives, such as identifying, evaluating and making financial investments in life sciences assets......



Myrexis, Inc.
Ticker: MYRX
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 801 214-7800
Fax: 801 214-7992
Address: 630 Fifth Avenue
Suite 2260
New York, NY 10020 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing
ContactsDescription
Jonathan CouchmanCEO/Chairman of the Board/Director/President
Andrea KendellCFO/Chief Accounting Officer
Myrexis Inc is engaged in evaluating strategic alternatives, such as identifying, evaluating and making financial investments in life sciences assets......See More See More

Auditor: Ernst & Young LLP
Legal Advisor: Mintz, Levin, Cohen, Ferris, Glovsky and Popeo, P.C.
$USD, In whole numbers,
except marked * or %
2013201220112010
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: